|
|
|||
Description:The ACADVL gene encodes very long-chain
acyl-CoA dehydrogenase (VLCAD). VLCAD differs from other acyl-CoA dehydrogenases
(SCAD, MCAD, and LCAD) in its size, structure, and intramitochondrial
distribution. Human liver VLCAD is a mitochondrial inner membrane bound
154-kD homodimer whereas the other ACADs are homotetramers located
in the mitochondrial matrix. The VLCAD enzyme catalyzes the major part
of mitochondrial palmitoyl-CoA dehydrogenation in liver, heart, skeletal
muscle, and skin fibroblasts. It’s specific activity toward palmitoyl-CoA
is10 times higher than LCAD. VLCAD deficiency causes autosomal recessive
fatty acid oxidation disorders that can be classified clinically into
3 forms: a severe early-onset form with high incidence of cardiomyopathy
and high mortality; an intermediate form with childhood onset, usually
with hypoketotic hypoglycemia and a more favorable outcome; and an
adult-onset, myopathic form with isolated skeletal muscle involvement,
rhabdomyolysis, and myoglobinuria after exercise or fasting. Reasons for Referral:
Testing Methodology:The exons and flanking intronic regions of ACADVL gene are PCR amplified and sequenced in the forward and reverse directions. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adult: 5 cc; Child & Infant: 3 cc Turnaround Time:4 weeks CPT Codes and Prices:
Index: 83891, 83904x40, 83898x20, 83912, 83894x2 Shipping InformationForms:>> Gene Sequencing Requisition or Mitochondrial Requisition - Mitochondrial Diagnostic Checklist is included Test Code:
Index: 3355 |